Hexane Fraction of

Adenophora triphylla var. japonica VEGFR2 angiogenesis erlotinib resistance lung cancer

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 29 12 2023
revised: 20 01 2024
accepted: 24 01 2024
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 10 2 2024
Statut: epublish

Résumé

The aim of this study was to investigate the anti-angiogenic effects of the hexane fraction of

Identifiants

pubmed: 38338342
pii: molecules29030597
doi: 10.3390/molecules29030597
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : 2019R1F1A1059588
Organisme : National Research Foundation of Korea
ID : 2021R1C1C100506211

Auteurs

Hyun-Ji Park (HJ)

Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea.

Jae-Hoon Jeong (JH)

Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea.

Yung-Hyun Choi (YH)

Department of Biochemistry, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea.

Shin-Hyung Park (SH)

Department of Pathology, College of Korean Medicine, Dong-eui University, Busan 47227, Republic of Korea.

Classifications MeSH